# FDA Inspection 1235782 - Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd. - March 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/tianjin-darentang-jingwanhong-pharmaceutical-co-ltd/cf9a8a5c-015b-4e96-9e37-569ab49147b1
Source feed: FDA_Inspections

> FDA Inspection 1235782 for Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd. on March 22, 2024. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235782
- Company Name: Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.
- Inspection Date: 2024-03-22
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 989604 - 2016-09-23](https://www.keypedia.com/records/fda_inspections/tianjin-darentang-jingwanhong-pharmaceutical-co-ltd/e3d0c7c3-89ce-4c86-a432-b4cbe876d0fb)

Company: https://www.keypedia.com/companies/tianjin-darentang-jingwanhong-pharmaceutical-co-ltd/10618087-4dda-4a3c-b6b9-65fd81c65493

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c